Recent publications have demonstrated the feasibility and utility of sequencing DNA or RNA from single cells [1, 2] . Th e power of these tools lies in their ability to reveal in mixtures of cells the identity and state of sub populations. Th e advantage of singlecell analysis over merely deep sequencing, whether for DNA or RNA, lies in the ability of the former to isolate diff erences and to phase possibly multiple diff erences within subpopu la tions. Th e future applications of these technologies are the topic of this brief article.
I will assume throughout that in the near future assess ing both DNA and RNA content simultaneously from hundreds to thousands of single cells will be quanti tatively accurate, as complete as needed, and aff ordable. It follows from these assumptions that knowledge of chromatin confi guration and DNA methylation in single cells will also be attainable. I will not consider what is possible by assaying the protein content of single cells, either by microscopy or mass spectroscopy, or by using methods not yet invented. Also, I will not focus on the many applications of this technology in oncology, such as in outcome research and early detection, as these appli ca tions are ongoing and have been widely discussed else where [3] . Instead, I want to speculate on basic applica tions to cell biology, theory of disease and diagnosis.
Basic cell and organismal biology
Much of what we know about cell biology is derived from perturbation experiments. An agent physical, chemical or genetic acts upon a cell and elicits a sequence of reactions, whether metabolic, molecular or structural. Unless this response is monitored by microscopy or some other method for observing single cells, the response is measured in a population of cells. Even superfi cially homogeneous populations contain cells in diff erent phases of the cell cycle, or that have stochastic variance, and thus may diff er in response to a perturbing agent. Th e temporal chain of reactions is often muddied.
Highthroughput singlecell nucleic acid analysis closes this gap, allowing the analysis of many single cells in a population, each responding to the perturbation. Each cell is a snapshot in the temporal chain of events, so mathematical and statistical methods are needed to piece together the response pathways [4] . Such analysis can reveal the causal linkage between events that were merely correlated before. Examples of potential applications abound, including studying the cellular response to DNA damage, hormones, contact with another cell, release from nutrient limitation and so forth.
In addition, the application of single cell genomic analysis should enable a clearer assessment of the nature of regulatory control. How tightly regulated are RNA levels from cell to cell? Is RNA expression (amount and splicing) monoallelic [5] ? Because under the assump tions outlined above chromatin confi guration and DNA methylation from single cells will also be attainable, we can anticipate being able to distinguish cause and eff ect when both transcription and chromatin change.
Any organ is made up of subpopulations of cell types, such as the various components of the blood, endothelial cells, stem cells and their descendants with varying degrees of functional specialization. Th ere is not a complete set of markers identifying all the population subtypes. Clustering singlecell RNA profi les is likely to yield a deeper recognition of cell types and to arm us with new tools for recognizing these cells. Most important among these are markers for stem cells and armed with such markers, singlecell analysis does allow the inspection of rare subpopulations [2] .
For a cell of known type, we can also speak of its 'state' . Cells of the same type may vary in state as they react to soluble factors, neighboring cells or synaptic inputs, transit through the cell cycle, and so on. In many of these cases, the state of the cell may be recognized from the expression profi le, and moreover the state may help us recognize which infl uences are acting on the cell. Th us, singlecell methods can be applied to such diverse problems as detecting the state of the stem cells in a given organ or understanding the transcriptional reaction of neurons to stimuli.
Pathobiology and diagnosis
Once armed with expectations about the normal state of tissues, we can use these expectations to investigate various disorders, such as diabetes and cancer. For example, in the latter, one can assess the cell types of host stroma, and their potential functions at the tumor site. Less obvious is the opportunity to analyze the basis of the medical disorders that result from the dysfunction of stem cells. Although speculative, it is likely that acquired problems of stem cells lie at the heart of many disorders of aging. These acquired problems can result from loss of DNA methylation or other epigenetic markers, and/or from accumulated somatic mutation such as loss of hetero zygosity that can unmask existing genetic vulnera bilities. Acquired autoimmunity, psoriasis or degenerative conditions, such as amyotrophic lateral sclerosis may be examples. Using singlecell methods, and our ability to distinguish cell types by their expression patterns, it should be possible to directly search for the presence of pathogenic somatic mutations in subtypes of dysfunc tional tissues.
In the future many tissue assays could be performed by singlecell methods, minimizing the necessary sample size and thereby lessening the stress of the biopsy procedure on the patient. The opportunities for cancer diagnosis from biopsies or fluid samples are clear. The most extreme example is preimplantation genetic screen ing, where an assay of a single cell might guide embryo selection. A less obvious but broader set of diagnostics could be based on analysis of blood cells. The blood is the highway of the body, and it is likely that the cells that traffic there reflect specific defense and repair functions, as well as hints of proliferative disorders. For example, the state of immune cells might reflect the type of invading pathogen that the body is fighting, and damage to a particular organ might be reflected in the type of stem cell that is being recruited from the marrow. Learning to interpret the state and identity of cells in the blood from the RNAs they produce should be seen as a logical next step in the progression of bloodbased clinical testing.
Clearly, there is far more to a cell than its DNA and RNA content. Nevertheless, highthroughput singlecell nucleic analysis has many applications to basic bio medi cal research. In time, these methods will alter medical care by maximizing the utility of minimal biopsy samples, and thereby improving treatment with earlier diagnosis using less invasive procedures.
